Business Context and Reporting Period
This Form 8-K Current Report, dated September 22, 2020, covers GoodRx Holdings, Inc. (GDRX), a Delaware corporation. The report details the closing of the Company's Initial Public Offering (IPO) on September 25, 2020, and the execution of related corporate governance agreements.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses on capital structure changes resulting from the IPO.
- Shares Sold by Company: 28,615,034 shares of Class A Common Stock (including 5,192,307 shares from the full exercise of the underwriters' option).
- Shares Sold by Existing Stockholders: 11,192,657 shares.
- Total Shares Offered: 39,807,691 shares.
- Offering Price: $33.00 per share.
- Trading Symbol: GDRX on The Nasdaq Stock Market LLC.
Material Changes
The primary material change is the transition from a private to a public company via the IPO. Additionally, the Company entered into a Stockholders Agreement on September 22, 2020, with entities affiliated with Silver Lake, Francisco Partners, Spectrum, and Idea Men, LLC, who are beneficial owners of more than 5% of the outstanding stock.
Guidance, Outlook, and Corporate Actions
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies beyond standard IPO disclosures.
Key corporate actions include:
- Execution of a Stockholders Agreement (Exhibit 10.1).
- Filing of an Amended and Restated Certificate of Incorporation (Exhibit 3.1).
- Adoption of Amended and Restated Bylaws (Exhibit 3.2), effective September 25, 2020.
Investor Verification Checklist
- Verify the final prospectus for details on "Certain Relationships and Related Party Transactions."
- Review the Amended and Restated Certificate of Incorporation and Bylaws for specific governance terms.
- Confirm the beneficial ownership percentages of Silver Lake, Francisco Partners, Spectrum, and Idea Men, LLC post-IPO.
- Check subsequent filings for the actual net proceeds received by the Company after underwriting discounts and expenses.